Autopsy report · NCT04826029
Impact of Systematic Imaging for Follow up of Patients With Ovarian, Fallopian Tube or Primary Peritoneum Cancer
Cause of deathOther
“No longer feasible because of new recommendations (RPC St Paul de Vence) which advocate the performance of systematic imaging in addition to CA 125 in patients treated in first line maintenance in order not to ignore a relapse (2021).”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Conditions
- Advanced Stage Serous Epithelial Cancer of the Ovary; Advanced Stage Cancer of Tubes; Advanced Stage Cancer of Peritoneum
- Interventions
- Standard strategy; Follow-up strategy
- Participants
- 0
- Sites
- 1
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.